Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-03-29
1999-12-21
Walsh, Stephen
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 530399, A61K 3818, C07K 1449
Patent
active
060049294
ABSTRACT:
Dimeric proteins having substantially the same biological activity as PDGF are disclosed. More specifically, the protein may have two substantially identical polypeptide chains, each of the chains being substantially homologous to the A-chain of PDGF. Alternatively, the protein may have two polypeptide chains that are substantially identical to the A-chain of PDGF. In addition, proteins comprising polypeptides that are variants or derivatives of the A-chain of PDGF are also disclosed. Therapeutic compositions containing these proteins and methods for enhancing the wound-healing process in warm-blooded animals are also disclosed.
REFERENCES:
patent: 4889919 (1989-12-01), Murray et al.
Betsholtz et al. (Apr. 24, 1986) Nature 320, 695-699.
Heldin et al. (1980) J. Cell. Phys. 105, 235-246.
Deuel et al. (1984) J. Clin. Invest. 74, 669-676.
Heldin et al. (Feb. 6, 1986) Nature 319, 511-514.
Betsholtz et al., Biochemical and Biophysical Research Communications 117: 176-182, 1983.
Betsholtz et al., Cell 39: 447-457, 1984.
Kelly James D.
Murray Mark J.
Brown Karen E.
Parker Gary E.
Walsh Stephen
ZymoGenetics Inc.
LandOfFree
Biologically active PDGF A-chain homodimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active PDGF A-chain homodimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active PDGF A-chain homodimers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505094